Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Endocrine Reviews · 10.01.2025 · 46 (1) · 80-148
DOI: 10.1210/endrev/bnae026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 06.09.2024. Verfasst von Robert Krysiak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-555 Katowice, Poland. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 339 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Magnus Bergvall Foundation, Karolinska Institutet and Stockholm County Council, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Treatment of classic congenital adrenal hyperplasia (CAH) is directed at replacing deficient hormones and reducing androgen excess. However, even in the era of early diagnosis and lifelong hormonal substitution, the presence of CAH is still associated with numerous complications and also with increased mortality. The aim of this article was to create an authoritative and balanced review concerning cardiometabolic risk in patients with CAH. The authors searched all major databases and scanned reference lists of all potentially eligible articles to find relevant articles. The risk was compared with that in other forms of adrenal insufficiency. The reviewed articles, most of which were published recently, provided conflicting results, which can be partially explained by differences in the inclusion criteria and treatment, small sample sizes, and gene–environment interactions. However, many studies showed that the presence of CAH is associated with an increased risk of weight gain, worsening of insulin sensitivity, high blood pressure, endothelial dysfunction, early atherosclerotic changes in the vascular wall, and left ventricular diastolic dysfunction. These complications were more consistently reported in patients with classic than nonclassic CAH and were in part related to hormonal and functional abnormalities associated with this disorder and/or to the impact of overtreatment and undertreatment. An analysis of available studies suggests that individuals with classic CAH are at increased cardiometabolic risk. Excess cardiovascular and metabolic morbidity is likely multifactorial, related to glucocorticoid overtreatment, imperfect adrenal hormone replacement therapy, androgen excess, and adrenomedullary failure. Cardiometabolic effects of new therapeutic approaches require future targeted studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, 40-555 Katowice, Poland.
- Amalia Children's Hospital, Radboud University Medical Centre, 6500 Nijmegen, The Netherlands.
- Medizinische Klinik und Poliklinik IV, LMU Klinikum München, 80336 Munich, Germany.
- Department of Endocrinology and Reproductive Medicine, Hôpital Pitié Salpêtrière, Sorbonne University Medicine, 75651 Paris, France.
- Department of Endocrinology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden.
ORCID-Profile: Nicole Reisch, Philippe Touraine, Henrik Falhammar
Förderung
- Magnus Bergvall Foundation
- Karolinska Institutet and Stockholm County Council
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Krysiak, R., Claahsen-van der Grinten, H. L., Reisch, N., Touraine, P., & Falhammar, H. (2025). Cardiometabolic Aspects of Congenital Adrenal Hyperplasia. Endocrine Reviews, 46(1), 80-148. https://doi.org/10.1210/endrev/bnae026
Vancouver
Krysiak R, Claahsen-van der Grinten HL, Reisch N, Touraine P, Falhammar H. Cardiometabolic Aspects of Congenital Adrenal Hyperplasia. Endocrine Reviews. 2025;46(1):80-148. doi:10.1210/endrev/bnae026
BibTeX
@article{Krysiak2025,
author = {Krysiak, Robert and Claahsen-van der Grinten, Hedi L and Reisch, Nicole and Touraine, Philippe and Falhammar, Henrik},
title = {Cardiometabolic Aspects of Congenital Adrenal Hyperplasia},
journal = {Endocrine Reviews},
year = {2025},
volume = {46},
number = {1},
pages = {80--148},
doi = {10.1210/endrev/bnae026}
}
EUVIMED